These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7705112)

  • 1. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France.
    Dautzenberg B; Piperno D; Diot P; Truffot-Pernot C; Chauvin JP
    Chest; 1995 Apr; 107(4):1035-40. PubMed ID: 7705112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
    Kadota JI; Kurashima A; Suzuki K
    J Infect Chemother; 2017 May; 23(5):293-300. PubMed ID: 28254517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE; Brown BA; Cegielski P; Murphy DT; Wallace RJ
    Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
    Kobashi Y; Matsushima T
    Intern Med; 2003 Aug; 42(8):670-5. PubMed ID: 12924489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries.
    Roussel G; Igual J
    Int J Tuberc Lung Dis; 1998 Jun; 2(6):462-70. PubMed ID: 9626603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
    Fournier S; Burguière AM; Flahault A; Vincent V; Treilhou MP; Eliaszewicz M
    Eur J Clin Microbiol Infect Dis; 1999 Jan; 18(1):16-22. PubMed ID: 10192709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS.
    Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR
    Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.
    Dautzenberg B; Saint Marc T; Meyohas MC; Eliaszewitch M; Haniez F; Rogues AM; De Wit S; Cotte L; Chauvin JP; Grosset J
    Arch Intern Med; 1993 Feb; 153(3):368-72. PubMed ID: 8427539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
    Dautzenberg B; Saint-Marc T; Durant J; Reynes J; Meyohas MC; Legrand MF; Truffot C; Chauvin JP
    Rev Mal Respir; 1994; 11(3):271-6. PubMed ID: 8041990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
    Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
    Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
    BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine.
    Field SK; Cowie RL
    Chest; 2003 Oct; 124(4):1482-6. PubMed ID: 14555583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
    Tanaka E; Kimoto T; Tsuyuguchi K; Watanabe I; Matsumoto H; Niimi A; Suzuki K; Murayama T; Amitani R; Kuze F
    Am J Respir Crit Care Med; 1999 Sep; 160(3):866-72. PubMed ID: 10471610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases].
    Saint-Marc T; Marneff E; Touraine JL
    Presse Med; 1993 Dec; 22(38):1903-7. PubMed ID: 8121903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.
    Wallace RJ; Brown BA; Griffith DE; Girard WM; Murphy DT; Onyi GO; Steingrube VA; Mazurek GH
    Am J Respir Crit Care Med; 1994 May; 149(5):1335-41. PubMed ID: 8173775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
    Hasegawa N; Nishimura T; Ohtani S; Takeshita K; Fukunaga K; Tasaka S; Urano T; Ishii K; Miyairi M; Ishizaka A
    Chest; 2009 Dec; 136(6):1569-1575. PubMed ID: 19542259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.